As Luteolin reduced the levels of activated PI3K/Akt/mTOR signaling cascade, the combination of Luteolin and PI3K, Akt, or mTOR inhibitors resulted in the synergistic increase in apoptosis in Tamoxifen-resistant ER-positive breast cancer cells [124]. The gene discussed is AKT1; the disease is breast carcinoma.